A team of polish scientists – including Michał Świerniak, M.D, Anna Wójcicka, M.D. and Prof. Krystian Jażdżewski – have discovered a method for more effective diagnosis of patients with thyroid cancer at the most risk of aggressive spread of the disease.
Doctors and geneticists from the Medical University of Warsaw, the Centre of New Technologies at the University of Warsaw, and the Maria Skłodowska-Curie Institute of Oncology in Warsaw, showed that the severity of the disease is linked with the presence of an inborn mutation in the DIRC3 gene. In other words, the presence of this gene mutation means the given patient can be assigned to the high-risk group.
To find out more about the discovery – please follow the link.